Centrix to launch dual decongestant and cough suppressant in US
This article was originally published in Scrip
Executive Summary
Centrix Pharmaceutical plans to launch Clofera (chlophedianol HCl/ pseudoephedrine HCl) for the temporary relief of cough and nasal congestion due to common colds, hay fever or other upper respiratory allergies, in the US by the end of September.